Production (Stage)
Bolt Biotherapeutics, Inc.
BOLT
$5.94
$0.172.95%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 38.84M | 47.32M | 53.80M | 73.70M | 91.35M |
| Total Receivables | 710.00K | 807.50K | 425.00K | 200.00K | 900.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.18M | 1.84M | 2.13M | 2.73M | 2.81M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 784.00K | 839.00K | 792.00K | -- | -- |
| Total Current Assets | 42.51M | 50.81M | 57.15M | 76.63M | 95.06M |
|
|
|||||
| Total Current Assets | 42.51M | 50.81M | 57.15M | 76.63M | 95.06M |
| Net Property, Plant & Equipment | 23.21M | 24.90M | 20.32M | 21.64M | 22.85M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.03M | 1.04M | 1.27M | 2.07M | 3.53M |
| Total Assets | 85.86M | 99.63M | 109.33M | 124.18M | 142.89M |
|
|
|||||
| Total Accounts Payable | 1.53M | 1.51M | 1.48M | 2.63M | 2.22M |
| Total Accrued Expenses | 6.25M | 8.34M | 10.43M | 7.35M | 9.71M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.40M | 2.25M | 2.82M | 3.00M | 2.89M |
| Total Finance Division Other Current Liabilities | 3.38M | 3.75M | 3.35M | 4.92M | 1.91M |
| Total Other Current Liabilities | 3.38M | 3.75M | 3.35M | 4.92M | 1.91M |
| Total Current Liabilities | 13.56M | 15.86M | 18.08M | 17.90M | 16.72M |
|
|
|||||
| Total Current Liabilities | 13.56M | 15.86M | 18.08M | 17.90M | 16.72M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 22.31M | 22.96M | 15.35M | 15.90M | 16.68M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.18M | 3.62M | 3.87M | 4.52M | 5.33M |
| Total Liabilities | 39.05M | 42.43M | 37.30M | 38.32M | 38.73M |
|
|
|||||
| Common Stock & APIC | 485.21M | 484.50M | 483.29M | 482.20M | 479.29M |
| Retained Earnings | -438.44M | -427.40M | -411.47M | -396.29M | -375.10M |
| Treasury Stock & Other | 40.00K | 97.00K | 205.00K | -44.00K | -36.00K |
| Total Common Equity | 46.81M | 57.20M | 72.03M | 85.86M | 104.16M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 46.81M | 57.20M | 72.03M | 85.86M | 104.16M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 46.81M | 57.20M | 72.03M | 85.86M | 104.16M |
|
|
|||||